NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 3 நாட்களுக்கு முன்இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Zodiac-JRD-MKJ Announces ₹40 Cr Rights Issue at ₹25/Share; 145:100 Ratio
Zodiac-JRD-MKJ Limited has released its Letter of Offer for a Rights Issue of up to 1,60,00,000 equity shares to raise up to ₹4,000 lakhs (₹40 crore). The shares are offered at ₹25 per share (₹10 face value plus ₹15 premium), representing a discount to the recent market price of ₹36.8. The rights entitlement ratio is set at 145 rights shares for every 100 existing shares held as of the record date, November 11, 2026. Relative to the company's existing market cap of ₹43 crore, the ₹40 crore fundraise represents a massive ~93% addition to the equity base.
உச்சம் நம்பிக்கை
என்ன மாறியதுZodiac-JRD-MKJ filed its Letter of Offer and schedule for a ₹40 crore rights issue.
ஏன் இது முக்கியம்The fundraise of ₹40 crore nearly matches the company's current market cap of ₹43 crore, leading to substantial equity dilution (145 new shares per 100 existing shares) while providing fresh capital for operations or growth.
வெளியீட்டு அளவு: ₹4,000 லட்சம்Issue price per share: ₹25Rights ratio: 145:100Issue size vs Market Cap: ~93%ரெக்கார்ட் தேதி: நவம்பர் 11, 2026
📅 குறுகிய காலம்The stock will likely see ex-rights price adjustments around the November 11 record date, alongside active trading in Rights Entitlements (REs) starting mid-November.
📈 நீண்ட காலம்Deployment of the ₹40 crore proceeds will be critical to determine whether return ratios (ROCE was 5.1%) and EPS can recover following severe equity dilution.
⚠ அபாய எச்சரிக்கைகள்
Heavy equity dilution given the 145:100 ratio
Risk of non-participation leading to significant value transfer/dilution for existing shareholders
👀 கவனிக்க வேண்டியவை
Existing shareholders should track the record date of November 11, 2026, and evaluate participation or renunciation of rights entitlements between November 19 and November 30, 2026.
Zodiac-JRD-MKJ Approves ₹40 Cr Rights Issue at ₹25/Share, 145:100 Ratio
Zodiac-JRD-MKJ Ltd has finalized terms for a Rights Issue of up to ₹40 crore (₹4,000 lakhs) by issuing up to 1.60 crore shares at ₹25 each (face value ₹10 plus ₹15 premium). This fundraise is massive relative to the company's current market capitalization of ₹43 crore (~93%). The entitlement ratio is set at 145 rights shares for every 100 equity shares held as of the record date on November 11, 2026. The issue will open on November 19, 2026, and close on December 3, 2026, expanding the share count from 1.09 crore to up to 2.70 crore shares upon full subscription.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe Board approved the detailed schedule and pricing for a ₹40 crore Rights Issue following in-principle approval from BSE.
ஏன் இது முக்கியம்The fundraise represents ~93% of the company's market cap and nearly matches its annual revenue of ₹45 crore, leading to significant equity dilution (share base increases by ~146%) but providing substantial growth capital.
Rights Issue Size: ₹ 4000 lakhsIssue vs Market Cap: ~93%Rights Issue Price: ₹ 25/-Entitlement Ratio: 145:100ரெக்கார்ட் தேதி: புதன், நவம்பர் 11, 2026Pre-issue Shares: 1,09,75,625
📅 குறுகிய காலம்Expect trading volatility around the record date (Nov 11) and during the RE trading window (closing Nov 30), as shares adjust for the dilution and discount.
📈 நீண்ட காலம்Will structurally expand the company's net worth and cash balance; long-term performance hinges on whether the capital is deployed into high-ROCE jewellery expansion or working capital.
⚠ அபாய எச்சரிக்கைகள்
Severe EPS dilution given the 145.8% expansion in share count
Promoter subscription intent not stated; low promoter holding (31.8%) requires monitoring for dilution
👀 கவனிக்க வேண்டியவை
Eligible shareholders should track the record date of November 11, 2026, to receive Rights Entitlements (REs), and watch for the deployment details of the ₹40 crore proceeds in the Letter of Offer.
BSE In-Principle Approval Received for Up to ₹40 Cr Rights Issue; Board to Meet Nov 4
Zodiac-JRD-MKJ Ltd has secured in-principle approval from BSE Limited on November 3, 2026, for its proposed rights issue of equity shares of up to ₹40 crore. Following this approval, the Board of Directors will meet on November 4, 2026, to determine the issue price, entitlement ratio, record date, and other terms. The proposed raise of up to ₹40 crore is very large relative to the company's current market cap of ~₹43 crore (~93%) and TTM revenue of ₹45 crore (~89%), implying substantial potential equity dilution.
உச்சம் நம்பிக்கை
என்ன மாறியதுBSE granted in-principle clearance for the rights issue, allowing the company to proceed with fixing the issue price and entitlement terms.
ஏன் இது முக்கியம்A fundraise of up to ₹40 crore nearly equals the company's entire market capitalization and could cause major share capital expansion and equity dilution.
Rights Issue Size: not exceeding Rs. 40 CroresIssue vs Market Cap: ~93%Issue vs TTM Revenue: ~89%BSE Approval Date: நவம்பர் 3, 2026Board Meeting Date: நவம்பர் 4, 2026
📅 குறுகிய காலம்Market attention will focus on the pricing discount and ratio set on November 4, 2026, which will dictate immediate rights entitlement trading and share price adjustment.
📈 நீண்ட காலம்Deployment of the raised capital towards working capital or growth initiatives will be critical to determine whether return ratios (ROCE currently 5.1%) can improve post-dilution.
⚠ அபாய எச்சரிக்கைகள்
Significant equity dilution risk given the fundraise size relative to market cap (~93%)
Subscription risk depending on pricing discount and promoter participation
👀 கவனிக்க வேண்டியவை
Track the outcome of the November 4, 2026 board meeting for the announced rights issue price, discount to current market price, entitlement ratio, and record date.
Q2 PAT Jumps 116% YoY to ₹0.66 Cr; Approves 1.42 Lakh ESOPs
Zodiac-JRD-MKJ reported its Q2 FY27 standalone net profit at ₹66.20 lakhs (₹0.66 Cr), up 116% YoY from ₹30.63 lakhs in Q2 FY26. Standalone revenue from operations grew 18.9% YoY to ₹686.92 lakhs (₹6.87 Cr) compared to ₹577.72 lakhs in the prior year period. For H1 ended September 30, 2026, standalone profit after tax rose to ₹107.24 lakhs from ₹41.42 lakhs in H1 FY26. Additionally, the board approved granting 1,42,066 stock options at an exercise price of ₹10 per share under its ESOP Plan 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுZodiac-JRD-MKJ approved its unaudited financial results for Q2 and H1 ended September 30, 2026, alongside an ESOP grant of 1,42,066 options.
ஏன் இது முக்கியம்The company demonstrated notable bottom-line growth in Q2 on improved top-line scale, though operating cash flows remain strained due to working capital expansion.
📅 குறுகிய காலம்The sharp YoY profit doubling is likely to be viewed positively in the near term given the small earnings base.
📈 நீண்ட காலம்Sustained performance will depend on converting elevated inventory levels into cash flows and stabilizing trading margins.
⚠ அபாய எச்சரிக்கைகள்
Negative operating cash flow of ₹(29.00) lakhs in H1
High working capital lock-in with inventories at ₹7,001.81 lakhs relative to annual scale
👀 கவனிக்க வேண்டியவை
Track the full consolidated performance details and working capital management, particularly inventory buildup which stood at ₹7,001.81 lakhs as of September 30, 2026.
Zodiac-JRD-MKJ to increase Authorised Capital to ₹27 Cr; Rights Issue pending BSE approval
Zodiac-JRD-MKJ Ltd has approved its Q1 FY27 financial results and proposed a 50% increase in its authorized share capital from ₹18 crore to ₹27 crore. This capital expansion is a preparatory step for a planned Rights Issue, which is currently awaiting in-principle approval from BSE Limited. The company has also scheduled its 39th Annual General Meeting for September 24, 2026, and re-appointed its statutory auditor for a five-year term. Investors should note that the specific terms of the Rights Issue will be decided only after regulatory clearance.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company is expanding its legal capital limit to facilitate a future fundraise via a Rights Issue and has finalized its annual administrative calendar.
ஏன் இது முக்கியம்Increasing authorized capital is a necessary precursor to issuing new shares; the eventual Rights Issue will be critical for the company's liquidity or growth plans, given its small ₹41 Cr market cap.
Current Authorised Capital: ₹18,00,00,000Proposed Authorised Capital: ₹27,00,00,000Capital Increase %: 50%AGM Date: 24th செப்டம்பர், 2026சந்தை மதிப்பு: ₹41 கோடி
📅 குறுகிய காலம்The stock may remain range-bound as the market awaits the specific pricing and ratio of the Rights Issue and the detailed Q1 FY27 financial performance.
📈 நீண்ட காலம்The structural impact depends on the successful execution of the Rights Issue and how the management utilizes the fresh capital to improve its low OPM of 2.3%.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution risk from the upcoming Rights Issue
👀 கவனிக்க வேண்டியவை
Monitor for the BSE in-principle approval and subsequent board meeting where the Rights Issue price and entitlement ratio will be finalized, as this will impact equity dilution.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
₹40 Cr Rights Issue: Zodiac-JRD-MKJ Submits Draft Letter of Offer
Zodiac-JRD-MKJ Ltd has filed a Draft Letter of Offer for a Rights Issue to raise up to ₹40 crore. This is a massive fundraise relative to the company's current scale, representing approximately 97.5% of its total market capitalization (₹41 Cr) and 160% of its TTM revenue (₹25 Cr). The issue involves fully paid-up equity shares of face value ₹10 each, though the final price and entitlement ratio are yet to be determined. The company currently carries zero debt and has a net worth of ₹94 crore.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has formally initiated a major capital raising process by filing the Draft Letter of Offer with the exchange.
ஏன் இது முக்கியம்A fundraise of this magnitude relative to market cap will lead to significant equity dilution. However, it provides the company with substantial liquidity to potentially scale its gems and jewellery operations beyond its current ₹25 crore annual revenue base.
Proposed Issue Size: ₹40.00 கோடிIssue vs Market Cap: ~97.5%Issue vs TTM Revenue: ~161.8%Face Value: ₹10 per shareCurrent Net Worth: ₹94 கோடி
📅 குறுகிய காலம்The stock may experience volatility as the market reacts to the potential dilution and awaits the final pricing of the rights shares.
📈 நீண்ட காலம்If the capital is successfully deployed into high-margin jewellery segments, it could structurally transform the company's scale; otherwise, the massive dilution may weigh on EPS.
⚠ அபாய எச்சரிக்கைகள்
Significant equity dilution
Pricing risk (final price not yet disclosed)
Low historical operating margins (2.3%)
👀 கவனிக்க வேண்டியவை
Monitor the announcement of the final Rights Issue price and the record date to determine the cost of participation. Investors should review the 'Objects of the Issue' in the full DLOF to understand how this significant capital infusion will be deployed, given the current low operating margins of 2.3%.
₹40 Cr Rights Issue: Zodiac-JRD-MKJ to Fix Terms on August 12
Zodiac-JRD-MKJ has scheduled a board meeting on August 12, 2026, to finalize the terms of a proposed Rights Issue not exceeding ₹40 Crores. This fundraise is highly material, representing approximately 93% of the company's current market capitalization of ₹43 Crores. The board will also approve the un-audited financial results for Q1 FY27 and finalize details for the 39th Annual General Meeting. Investors should note that the company is currently debt-free with a net worth of ₹94 Crores, making this a significant capital infusion relative to its operations.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company is transitioning from a general approval of a fundraise to fixing the specific execution terms (price, date, and ratio) for a ₹40 Crore Rights Issue.
ஏன் இது முக்கியம்A fundraise of this magnitude (93% of market cap) is transformative for a micro-cap company with ₹25 Cr annual revenue, potentially providing capital for significant expansion or diversification.
Rights Issue Size: ₹40 CroresFundraise vs Market Cap: ~93%Current Market Cap: ₹43 கோடிTTM வருவாய்: ₹25 கோடிBoard Meeting Date: 12/08/2026
📅 குறுகிய காலம்The stock may experience volatility leading up to and following the August 12 meeting as the market prices in the dilution and the rights price.
📈 நீண்ட காலம்If the ₹40 Cr is deployed effectively into high-margin jewellery segments, it could significantly scale the company's small revenue base (₹25 Cr TTM).
⚠ அபாய எச்சரிக்கைகள்
Significant equity dilution
Recent slight decline in promoter holding
Execution risk in deploying capital nearly equal to current market cap
👀 கவனிக்க வேண்டியவை
Watch for the specific Rights Issue price and entitlement ratio on August 12, as these will determine the extent of equity dilution and the attractiveness of the offer for existing shareholders.
Rs 40 Cr Rights Issue: Zodiac-JRD-MKJ Approves Draft Letter of Offer
Zodiac-JRD-MKJ Ltd has approved the Draft Letter of Offer (DLOF) for a Rights Issue to raise up to Rs 40 crore. This fundraise is highly material, representing approximately 95% of the company's current market capitalization of Rs 42 crore and 160% of its TTM revenue of Rs 25 crore. While the board has set the upper limit for the raise, the specific issue price, rights ratio, and record date will be decided at a later meeting. The company currently operates with zero debt and a net worth of Rs 94 crore, making this a significant liquidity event.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has progressed from the initial board approval to the formal approval of the Draft Letter of Offer (DLOF) for its Rs 40 crore rights issue.
ஏன் இது முக்கியம்For a micro-cap company with Rs 25 crore in annual revenue, a Rs 40 crore fundraise is transformative. It could provide the necessary capital for a major business pivot or expansion, but it also poses a high risk of equity dilution for existing shareholders who do not participate.
Proposed Issue Size: Rs 40 கோடிIssue Size vs Market Cap: ~95%Issue Size vs TTM Revenue: ~162%Current Market Cap: Rs 42 கோடிFace Value per Share: Rs 10
📅 குறுகிய காலம்The stock price may experience volatility as the market reacts to the potential dilution and awaits the pricing of the rights shares.
📈 நீண்ட காலம்The long-term impact depends entirely on the deployment of the Rs 40 crore. Given the current low ROCE of 5.1%, the management's ability to generate higher returns on this new capital will be the key structural driver.
⚠ அபாய எச்சரிக்கைகள்
Significant equity dilution
Large fundraise relative to current business scale
Specific use of proceeds not yet detailed
👀 கவனிக்க வேண்டியவை
Investors should monitor upcoming announcements for the Rights Issue price and the entitlement ratio, which will determine the extent of equity dilution. It is critical to review the final Letter of Offer to understand the specific 'Objects of the Issue' and how the company intends to deploy such a large capital infusion relative to its current scale.
₹40 Crore Rights Issue Approved by Zodiac-JRD-MKJ Ltd
Zodiac-JRD-MKJ Ltd has approved a fundraise of up to ₹40 crore through a Rights Issue of equity shares. This is a massive capital infusion considering the company's current market capitalization is only ₹42 crore. The Board has delegated the finalization of the issue price, rights ratio, and record date to a specialized Rights Issue Committee. Investors should note that a fundraise of this magnitude relative to the company's size (160% of TTM revenue) suggests a significant shift in business scale or capital structure.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has transitioned from a debt-free, small-scale operation to seeking a capital injection nearly equal to its entire market value.
ஏன் இது முக்கியம்A fundraise of this scale is highly material; it could either fund a major business pivot/expansion or significantly dilute existing shareholders if the issue price is at a steep discount.
📅 குறுகிய காலம்The stock price may experience volatility as the market anticipates the dilution and awaits the specific pricing of the rights shares.
📈 நீண்ட காலம்If successfully deployed, ₹40 crore could fundamentally alter the company's ₹25 crore revenue base, but execution risk and dilution remain primary concerns.
⚠ அபாய எச்சரிக்கைகள்
Significant equity dilution
Utilization of funds not yet specified
Low promoter holding (31.8%) may be further diluted if they do not subscribe fully
👀 கவனிக்க வேண்டியவை
Monitor upcoming announcements regarding the Rights Issue price and record date. Evaluate the discount offered to the current market price (₹38.6) and the company's eventual disclosure on how these funds will be utilized.
Board Meeting on Aug 6 to Consider Fund Raising via Rights Issue
Zodiac-JRD-MKJ Ltd has scheduled a board meeting for August 6, 2026, to consider a proposal for raising funds through a Rights Issue. This comes at a time when the company has a micro-cap valuation of ₹38 Cr and a significant net worth of ₹94 Cr. The stock has seen a 33.2% decline over the last 12 months, and the promoter holding recently decreased slightly to 31.83%. The specific size and pricing of the issue will be determined at the upcoming meeting.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company is initiating a formal process to raise equity capital from existing shareholders through a Rights Issue.
ஏன் இது முக்கியம்For a micro-cap company with a ₹38 Cr market cap, a rights issue can lead to significant equity dilution or provide necessary capital for growth, especially given the current low P/B ratio of 0.4.
📅 குறுகிய காலம்The stock may experience volatility leading up to and following the August 6 meeting as the market reacts to the proposed issue price and ratio.
📈 நீண்ட காலம்The long-term impact depends on the utilization of the raised funds and whether the company can improve its low ROCE of 5.1%.
⚠ அபாய எச்சரிக்கைகள்
Equity dilution for non-participating shareholders
Recent slight decline in promoter holding
Low operating profit margins (2.3%)
👀 கவனிக்க வேண்டியவை
Investors should watch for the board's decision on August 6 regarding the Rights Issue price, the entitlement ratio, and the total amount intended to be raised.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
